MiR-125a/b regulates the activation of cancer stem cells in paclitaxel-resistant colon cancer

Cancer Investigation

Volumn 31, Issue 1, 2013, Pages 17-23

  Chen, Jixiang ^a   Chen, Yuxiang ^b   Chen, Zihua ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Cancer stem cells; Chemoresistance; Colon cancer; MiRNA; Paclitaxel

Indexed keywords

ALDEHYDE DEHYDROGENASE; MICRORNA; MICRORNA 125A; MICRORNA 125B; PACLITAXEL; PROTEIN MCL 1; UNCLASSIFIED DRUG;

ALDH1A3 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER MODEL; CANCER RESISTANCE; CANCER STEM CELL; CELL STRAIN HCT116; CELL STRAIN HT29; CELL SURVIVAL; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MCL1 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; UPREGULATION;

ALDEHYDE DEHYDROGENASE; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HT29 CELLS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASTIC STEM CELLS; PACLITAXEL; PROTO-ONCOGENE PROTEINS C-BCL-2; UP-REGULATION;

EID: 84872694538     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2012.743557     Document Type: Article

References (26)

1. Ades S. Adjuvant chemotherapy for colon cancer in the elderly: Moving from evidence to practice. Oncology 2009;23:162-167
2. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007;7:573-584 (Pubitemid 47106628)
3. Hiro J, Inoue Y, Toiyama Y, Yoshiyama S, Tanaka K, Mohri Y, Miki C, Kusunoki M. Possibility of paclitaxel as an alternative radiosensitizer to 5-fluorouracil for colon cancer. Oncol Rep 2010;24:1029-1034
4. Djeu JY, Wei S. Clusterin and chemoresistance. Adv Cancer Res 2009;105:77-92
5. Dai A, Huang Y, SadeeW. Growth factor signaling and resistance to cancer chemotherapy. Curr TopMed Chem 2004;4:1347-1356 (Pubitemid 39242877)
6. Dave B,Chang J. Treatment resistance in stem cells and breast cancer. J Mammary Gland Biol Neoplasia 2009;14:79-82
7. Douville J, Beaulieu R, Balicki D. ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev 2009;18:17-25
8. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M Geschwind DH, Bronner-Fraser M, Kornblum HI. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 2003;100:15178-15183 (Pubitemid 37518036)
9. Riveros-Rosas H, Julian-Sanchez A, Pina E. Enzymology of ethanol and acetaldehyde metabolism in mammals. ArchMed Res 1997;28:453-471 (Pubitemid 28014256)
10. Ma I, Allan AL. The role of human aldehyde dehydrogenase in normal and cancer stem cells, Stem Cell Rev 2010;7:292-306
11. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006;20:515-524 (Pubitemid 43345317)
12. Bagga S, Pasquinelli AE. Identification and analysis of microRNAs. Genet Eng (NY) 2006;27:1-20
13. Lewis BP, Shih IH, Jones-Rhoades MW,BartelDP, Burge CB. Prediction ofmammalian microRNA targets. Cell 2003;115:787-798
14. Schwickart M, Huang X, Lill JR, Liu J, Ferrando R, French DM Maecker H, O'Rourke K, Bazan F, Eastham-Anderson J, Yue P, Dornan D, Huang DC, Dixit VM. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 2010;463:103-107
15. Lestini BJ, Goldsmith KC, Fluchel MN, Liu X, Chen NL, Goyal B, Pawel BR, Hogarty MD. Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2- family antagonists. Cancer Biol Ther 2009;8:1587-1595
16. Balakrishnan A, Stearns AT, Park PJ, Dreyfuss JM, Ashley SW RhoadsDB, Tavakkolizadeh A. Upregulation of proapoptotic microRNA mir-125a after massive small bowel resection in rats. Ann Surg 2012; 255:747-753
17. Zeng CW, Zhang XJ, Lin KY, Ye H, Feng SY, Zhang H Chen YQ. Camptothecin induces apoptosis in cancer cells via microRNA-125b-mediated mitochondrial pathways. Mol Pharmacol 2012;81:578-586
18. Zhang X, Li Y, Huang Q,Wang H, Yan B, Dewhirst MW, Li CY. Increased resistance of tumor cells to hyperthermia mediated by integrin-linked kinase. Clin Cancer Res 2003;9:1155-1160 (Pubitemid 36323725)
19. Mi J, Zhang X, Rabbani ZN, Liu Y, Su A,Vujaskovic Z,Kontos CD Sullenger BA,Clary BM. H1RNApolymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity. Nucleic Acids Res 2006;34:3577-3584
20. Zhang X,Kon T,WangH, Li F,HuangQ, Rabbani ZN,Kirkpatrick JP, Vujaskovic Z, DewhirstMW, LiCY. Enhancement of hypoxiainduced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor- 1alpha. Cancer Res 2004;64:8139-8142 (Pubitemid 39491746)
21. Li J, Zhang Y, Zhao J, Kong F, Chen Y. Overexpression of miR- 22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells. Mol Cell Biochem 2011;357:31-38
22. McEwan DG, Brunton VG, Baillie GS, Leslie NR, Houslay MD Frame MC. Chemoresistant KM12C colon cancer cells are addicted to lowcyclicAMPlevels in a phosphodiesterase 4-regulated compartment via effects on phosphoinositide 3-kinase. Cancer Res 2007;67:5248-5257 (Pubitemid 46997263)
23. Kai K, Arima Y, Kamiya T, Saya H. Breast cancer stem cells. Breast Cancer 2010;17:80-85
24. Corti S, Locatelli F, Papadimitriou D, Donadoni C, Salani S, Del Bo R. Strazzer S, Bresolin N, Comi GP. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 2006;24:975-985 (Pubitemid 44464730)
25. Marchitti SA, BrockerC, StagosD,VasiliouV.Non-P450 aldehyde oxidizing enzymes: The aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol 2008;4:697-720 (Pubitemid 352003194)
26. Xiang Z, Luo H, Payton JE, Cain J, Ley TJ, Opterman JT, Tomasson MH. Mcl1 haploinsufficiency protects mice from Myc-induced acute myeloid leukemia. J Clin Invest 2010;120:2109-2118